メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
Scopus著者プロファイル
本田 仁
医学部・感染症科
h-index
1667
被引用数
22
h 指数
Pureの文献数とScopusの被引用数に基づいて算出されます
2007
2025
年別の研究成果
概要
フィンガープリント
ネットワーク
研究成果
(94)
類似のプロファイル
(6)
フィンガープリント
Hitoshi Hondaが活動している研究トピックを掘り下げます。このトピックラベルは、この研究者の研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Antiinfective Agent
100%
Tertiary Care
82%
COVID-19
64%
Infection
42%
Bloodstream Infection
35%
Clostridium Difficile Infection
35%
Cohort Effect
30%
Odds Ratio
30%
Antibiotics
27%
Hand Hygiene
26%
Cross Sectional Study
26%
Surgical Infection
22%
Health Care
21%
Antimicrobial Therapy
20%
Retrospective Cohort Study
19%
Observational Study
18%
Emergency Department
18%
Cholangitis
17%
Blood Culture
16%
Carbapenem
12%
Bacterial Meningitis
11%
Intensive Care Unit
11%
Prevalence
11%
Vaccine Hesitancy
10%
Time Series Analysis
9%
Consultation
9%
Infection Control
9%
Dentistry
8%
Vancomycin
8%
Neurology
8%
Gram-Negative Bacteria
8%
Ventilator-Associated Pneumonia
8%
Fusobacterium nucleatum
8%
Human Coronavirus OC43
8%
Coronavirinae
8%
Case-Control Study
8%
Topical Corticosteroid
8%
Retina Macula Cystoid Edema
8%
Cancer
8%
Systemic Candidiasis
8%
Central Nervous System Infection
8%
Hospital Management
8%
Mastitis
8%
Booster Dose
8%
Laparoscopic Surgery
8%
Immigrant
8%
Chorioretinitis
8%
Outpatient
8%
Stomach Surgery
8%
Heart Surgery
8%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
88%
Infection
37%
Clostridium Difficile Infection
26%
Vancomycin
26%
Disease
24%
Cohort Study
23%
Surgical Infection
22%
Antibiotic Agent
20%
Antimicrobial Therapy
19%
Prevalence
18%
Symptom
18%
Bloodstream Infection
17%
Antibiotics
17%
Cross Sectional Study
17%
Vaccination Policy
11%
Hospital Infection
11%
Cross-Sectional Study
10%
Prospective Cohort Study
9%
Methicillin Resistant Staphylococcus Aureus Infection
8%
Ventilator Associated Pneumonia
8%
Therapeutic Drug Monitoring
8%
Enterobacteriaceae
8%
Coronavirinae
8%
Metallo Beta Lactamase
8%
Invasive Candidiasis
8%
Case-Control Study
8%
Brain Abscess
8%
Cholangitis
8%
Observational Study
8%
Staphylococcal Bacteremia
8%
SARS Coronavirus
8%
Sarilumab
8%
Backache
8%
COVID-19 Vaccine
7%
All Cause Mortality
6%
Candidiasis
5%
Keyphrases
Japan
32%
Infectious Diseases Consultation
17%
Tokyo
15%
Tertiary Care Hospital
14%
Audit-and-feedback
13%
Stewardship
13%
Days of Therapy
11%
Surgical Antimicrobial Prophylaxis
11%
Prospective Audit
10%
Interrupted Time Series
10%
Success Strategies
8%
Adjusted Odds Ratio
8%
Mandatory Policy
8%
Multifaceted Intervention
8%
Current Recommendations
8%
Oriental Cholangiohepatitis
8%
Blood Culture Collection
8%
National Survey in Japan
8%
Post-COVID-19
8%
Hospital Cluster
8%
Admission Screening
8%
Cholangitis
8%
Laparoscopic Surgery
8%
Barriers to Adherence
8%
Enterobacteriaceae
8%
Bloodstream Infection
8%
Actinomycosis
8%
Inpatient Setting
8%
Sustainability Assessment
8%
Cystoid Macular Edema
8%
Carbapenem Use
8%
Therapeutic Drug Monitoring
8%
Antimicrobial Stewardship
8%
Invasive Candidiasis
8%
Wrist
8%
Program Vector
8%
Children's Hospital
8%
Vector Autoregressive Model
8%
Antibiotic Spectrum
8%
Off Periods
8%
Antimicrobial Therapy
8%
Mastitis
8%
Hepatic Malignancy
8%
Metallo-β-lactamase
8%
Rapidly Growing Mycobacteria
8%
Hand Hygiene Practice
8%
COVID-19
8%
Hand Hygiene Compliance
8%
Patient Contact
8%
Dispenser
8%
